| Literature DB >> 29342283 |
Tu Le Thi Phuong1, Sayaphet Rattanavong2, Manivanh Vongsouvath2, Viengmon Davong2, Nguyen Phu Huong Lan1,3, James I Campbell1,4, Thomas C Darton1,5, Guy E Thwaites1,4, Paul N Newton2,4, David A B Dance2,4,6, Stephen Baker1,4,7.
Abstract
Background: Invasive non-typhoidal Salmonella (iNTS) disease is a well-described cause of mortality in children and human immunodeficiency virus (HIV)-infected adults in sub-Saharan Africa. Additionally, there is an ill-defined burden of iNTS disease in Southeast Asia.Entities:
Keywords: Antimicrobial susceptibility; Bloodstream infections; HIV; Lao; NTS; Non-typhoidal Salmonella; Salmonella Typhimurium
Mesh:
Year: 2017 PMID: 29342283 PMCID: PMC5914354 DOI: 10.1093/trstmh/trx076
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184
Figure 1.Identified Salmonella serovars causing invasive and non-invasive disease in Lao and their antimicrobial susceptibility profiles. (a) Minimum spanning tree of 168 Laotian NTS isolates created using seven-allele MLST profiling; the sources of the organisms are colour coded (red, blood; blue, faeces). The sequence type (ST) of each allele profile is shown along with the inferred serovar. Clonal complexes (S. enterica Typhimurium, S. enterica Enteritidis, S. enterica Choleraesuis, S. enterica Stanley and S. enterica Weltevreden) are highlighted. The size of each ST group corresponds with the number of isolates with the same ST profile (scale shown) and the branches are labelled by the number of variable alleles between STs. (b) Bar graph showing the proportion of organisms (red, blood; blue, faeces) exhibiting non-susceptibility (including intermediate resistance) against ampicillin (AMP), amoxicillin/clavulanate (AMC), ceftazidime (CAZ), ceftriaxone (CRO), chloramphenicol (CHL), ciprofloxacin (CIP), gentamicin (GEN), nalidixic acid (NAL), ofloxacin (OFX) and trimethoprim-sulfamethoxazole (SXT). Asterisks signify statistically significant differences in the proportion of organisms with non-susceptibility against the individual antimicrobial (p<0.05, Fisher’s exact test).
The distribution of NTS serovars isolated from the blood and faecal specimens of patients in Lao PDR
| Serogroupa | Bloodstream isolates, n (%) (N=63) | Faecal isolates, n (%) (N=105) | p-Valuec | |
|---|---|---|---|---|
| B | Typhimurium | 19 (30.2) | 28 (26.7) | 0.625 |
| Stanley | 3 (4.8) | 15 (14.3) | 0.071 | |
| Paratyphi B | 0 | 5 (4.8) | 0.158 | |
| Derby | 0 | 2 (1.9) | 0.528 | |
| Bredeney | 0 | 1 (1.0) | 1.000 | |
| Agona | 0 | 1 (1.0) | 1.000 | |
| D | Enteritidis | 28 (44.4) | 7 (6.7) | |
| Panama/Miami/Koessen | 1 (1.6) | 2 (1.9) | 1.000 | |
| C1 | Choleraesuis | 11 (17.5) | 0 (0) | |
| Rissen | 1 (1.6) | 3 (2.9) | 1.000 | |
| Mbandaka | 0 | 1 (1.0) | 1.000 | |
| C2 | Albany | 0 | 1 (1.0) | 1.000 |
| Corvallis | 0 | 1 (1.0) | 1.000 | |
| Tananarive | 0 | 3 (2.9) | 1.000 | |
| E | Weltevreden | 0 | 14 (13.3) | |
| Anatum | 0 | 5 (7.5) | 0.158 | |
| Give | 0 | 6 (5.7) | 0.085 | |
| G | Worthington | 0 | 2 (1.9) | 0.528 |
| C/E/G | Unknown | 0 | 8 (7.6) | 0.026 |
aSerogroup determined by classical O serotyping.
bSerovar inferred by MLST profile.
cp-Values determined by Fisher’s exact test on the proportions of the specific Salmonella serovar isolated from blood and faecal specimens. Significant p-values in bold.
The clinical features of patients in Lao PDR with iNTS disease
| Characteristic | Value |
|---|---|
| Sex (male) | 27/62 (43.5) |
| Age (y), median (IQR) | 32 (17–44) |
| Days ill before hospital, median (IQR) | 6 (2–13) |
| Fever | 59/62 (95.2) |
| Rigors | 26/61 (42.6) |
| Headache | 40/62 (64.5) |
| Arthralgia | 24/60 (40.0) |
| Back pain | 14/59 (23.7) |
| Myalgia | 27/54 (50.0) |
| Jaundice | 9/54 (16.7) |
| Nausea | 19/61 (31.1) |
| Vomiting | 22/62 (35.5) |
| Dysuria | 4/60 (6.7) |
| Diarrhoea | 36/62 (58.1) |
| Constipation | 4/53 (7.5) |
| 3/44 (6.8) | |
| HIV seropositive | 6/50 (12.0) |
| Antimicrobial taken in the last 7 d | 15/41 (36.6) |
All values are n/N (%) unless otherwise noted.